Il Dong achieved 10.6% sales growth at 171.5 BW

Published: 2004-04-30 06:55:00

Updated: 2004-04-30 06:55:00

Il Dong pharmaceutical company reported that during 2003 fiscal year ended at Mar. 31 2004 the comparative management performance over the previous year was 10.6% up of the sales growth at 171,500 million won, 8% up of the ordinary income at 23.3 billion won, 6.9% up of the net income at 14.1 bil...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK